The drug discovery process involves the discovery and designing of new drugs. A newly discovered drug should possess many qualities such as affinity, selectivity efficacy, potency, metabolic stability, and oral bioavailability. The drug discovery process mainly involves steps like the identification and validation of candidates, synthesis, characterization, screening, and assays for therapeutic efficacy.
Know anyone building innovative solutions that belong in this 'Drug Discovery'?
Coming to Boston this May, the 2nd Induced Proximity-Based Drug Discovery Summit is the only industry and academic dedicated summit focused on exciting innovations and emerging case studies to establish novel strategies of identifying and optimizing drug design, physiological properties and therapeutic applications of induced proximity-based drugs.
This multidisciplinary summit will be gathering 100+ of the industry drug discovery leaders in large and small molecule disciplines to discuss how the phenomenon of induced proximity can be leveraged to precisely engineer biological outcomes such as post-translational modifications and degradation of high value targets in oncology and beyond.
The pandemic triggered seismic shifts across the healthcare sector, from innovations in drug discovery, development and treatment to new approaches in patient care. As we combat new variants and slowly shift toward the pandemic-recovery phase, what are some of the lessons learned? How can we address the most pressing healthcare issues going forward? Join us for WSJ Health Forum and hear from leaders with a wide range of perspectives and expertise as we look at what’s next for the business and science of health.
Advanced Machine Learning and Artificial Intelligence for Innovative Drug Discovery & Development Forum will bring together global pharmaceutical industry leaders to exchange experience and share the latest discoveries using artificial intelligence (AI) and machine learning (ML) to enhance service delivery levels in health-related industries and pharmaceutical industries. During this two-day session, senior executives, experts, and business professionals will join in-depth panel discussions, view practical case studies, attend interactive sessions, and participate in development workshops.
The summit will allow you to gain knowledge on the inhibition and activation of the Wnt pathway. The Wnt & β-Catenin Targeted Drug Discovery Summit is the only meeting uniting leading pharma, pioneering biotechs, and reputed academics under a mutual and ambitious objective of accelerating your novel Wnt/β-catenin candidates into clinic and market.
Top-level Industry leaders from around 25+ Countries come to join DDIP and leave with an exceptional experience that they return to the conferences year after year. Delegates attending our event are asked to complete a questionnaire, which confirms their R&D budget.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our